Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Subscriptions

The prevalence of chronic obstructive pulmonary disease (COPD) in individuals with diabetes, hypertension, asthma, or mood/anxiety disorders: A Canadian population study

Pat Camp, Darcy Marciniuk, Marieve Doucet, Teresa To, Robert Prosser, Anita Kozyrskyj, Nancy Garvey, Kim Reimer, S. Vanderloo, Charles Gilbert, Louise McRae, Andrea Gershon
European Respiratory Journal 2012 40: P452; DOI:
Pat Camp
1James Hogg Research Centre, University of British Columbia, Vancouver, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Darcy Marciniuk
2Respiratory Division, University of Saskatchewan, Saskatoon, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marieve Doucet
3Institut National de Sante Publique, Government of Quebec, Quebec, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Teresa To
4Institute for Clinical Evaluative Sciences, Institute for Clinical Evaluative Sciences, Toronto, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert Prosser
5RJ Prosser and Associates, RJ Prosser and Associates, Vancouver, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anita Kozyrskyj
6Department of Pediatrics, University of Alberta, Edmonton, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nancy Garvey
7Ministry of Health and Long Term Care, Government of Ontario, Toronto, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kim Reimer
8Ministry of Health, Government of British Columbia, Victoria, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
S. Vanderloo
9Public Health Agency of Canada, Government of Canada, Ottawa, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Charles Gilbert
9Public Health Agency of Canada, Government of Canada, Ottawa, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Louise McRae
9Public Health Agency of Canada, Government of Canada, Ottawa, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrea Gershon
4Institute for Clinical Evaluative Sciences, Institute for Clinical Evaluative Sciences, Toronto, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Abstract

There is little information on the prevalence of COPD among people with other chronic conditions. We determined the cross sectional prevalence of COPD among Canadians with diabetes, asthma, hypertension, and mood/anxiety disorders. We also compared the all-cause mortality between individuals with these other diseases with/without COPD.

Methods: Using the Canadian Chronic Disease Surveillance System (CCDSS), we analyzed 2008/2009 administrative health data for Canadians aged 35 years and older, from 12 of 13 provinces/territories. COPD, diabetes, hypertension, mood/anxiety disorders and asthma were identified using ICD9/10 codes from physician billing and hospitalization records. Results: The prevalence of COPD among Canadians aged 35 years and older was 8.2%. The prevalence of COPD among people with diabetes, hypertension, mood/anxiety disorder and asthma was respectively 11.4% (95% confidence interval (CI) 11.35, 11.44), 10.0% (95%CI 9.99, 10.04), 11.6%, (95%CI 11.57, 11.66) and 26.3% (95%CI 26.20, 26.35). In addition, a diagnosis of COPD was associated with a 140% increase in mortality among people with diabetes and a 154% increase in mortality among people with hypertension (comorbid mortality among people with asthma or mood/anxiety disorders could not be calculated because the data were not available).

Conclusions: COPD is a prevalent comorbid condition for individuals with asthma, mood/anxiety disorder, diabetes and hypertension and comorbid COPD is associated with higher mortality. An integrated care approach to these patients may optimize health outcomes and reduce the burden of chronic disease.

  • COPD - diagnosis
  • Epidemiology
  • Public health
  • © 2012 ERS
Previous
Back to top
Vol 40 Issue Suppl 56 Table of Contents
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
The prevalence of chronic obstructive pulmonary disease (COPD) in individuals with diabetes, hypertension, asthma, or mood/anxiety disorders: A Canadian population study
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
The prevalence of chronic obstructive pulmonary disease (COPD) in individuals with diabetes, hypertension, asthma, or mood/anxiety disorders: A Canadian population study
Pat Camp, Darcy Marciniuk, Marieve Doucet, Teresa To, Robert Prosser, Anita Kozyrskyj, Nancy Garvey, Kim Reimer, S. Vanderloo, Charles Gilbert, Louise McRae, Andrea Gershon
European Respiratory Journal Sep 2012, 40 (Suppl 56) P452;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
The prevalence of chronic obstructive pulmonary disease (COPD) in individuals with diabetes, hypertension, asthma, or mood/anxiety disorders: A Canadian population study
Pat Camp, Darcy Marciniuk, Marieve Doucet, Teresa To, Robert Prosser, Anita Kozyrskyj, Nancy Garvey, Kim Reimer, S. Vanderloo, Charles Gilbert, Louise McRae, Andrea Gershon
European Respiratory Journal Sep 2012, 40 (Suppl 56) P452;
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
  • Info & Metrics
  • PDF
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Longitudinal changes in prevalence of chronic bronchitis in rural people
  • Associations between severity and duration of sleep-disordered breathing and brain tissue volume
  • Trends in mortality from respiratory diseases in Greece during the financial crisis
Show more 6.1 Epidemiology

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society